Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 From Its Phase 1 Trial of Pas-004 in Advanced Cancer Patients
Pasithea Therapeutics宣佈在其針對晚期癌症患者的1期試驗中,已完成第6組患者的入組和初始給藥。
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 From Its Phase 1 Trial of Pas-004 in Advanced Cancer Patients
Pasithea Therapeutics宣佈在其針對晚期癌症患者的1期試驗中,已完成第6組患者的入組和初始給藥。
風險及免責聲明
使用瀏覽器的分享功能,分享給你的好友吧
- 没有更多了 -